Gelregroen JV Signature RijkswaTaat and contract with Dutch highway project
Rijkswaterstaat, the operational division of the Dutch Ministry of Infrastructure and Water Management, has sealed off a key contract with the Gelregroen Joint Venture (JV) for the Dutch expressway project.
The Gelregroen JV, consisting of Hochtief (40%), John Laing (40%), Dura Vermeer (10%), and Besix (10%), will undertake the planning, construction and subsequent maintenance of the project.
The consortium that runs the work consists of Hochtief, Dura Vermeer, Besix and Van Oord, each holding a 25% stake.
Set in the Arnhem area, the project will expand the A15 highway by 12 km, while the A12 and A15 roads will expand additional lanes over 23 km.
The contract also includes funding, operating and maintaining the highway through 2051.
The project, awarded to the JV in 2020, faced delays due to appeals in the country’s highest administrative court, preventing the start of work.
The project is currently scheduled to begin in January 2026, with new sections of the A15 Expressway and additional A12/A15 lanes expected to open by the end of 2031.
As construction progresses, the project will include the construction of 45 bridge structures, 10 traffic junctions and additional noise barriers.
The new bridge on the Pannadensch Canal, which is approximately 2.5km long, will serve as the highlight of the project.
Sustainability is a key focus of a project and affects the planning, construction and operational stages.
The Gelregroen name reflects an environmentally-focused design, with developments including material reuse and methods of green construction.
Last month, Hochtief has partnered with the Cloud Solutions Provider Ionos Group, and Expression of interest He was interested in the construction and operation of the AI ”GigaFactory” in Europe, so he joined the European Commission.
“The Gelregroen JV Sign Singiol Agreement is a Agreement between RijkswaTaat and the Dutch Highway Project” was originally created and published. World Construction Networka brand owned by GlobalData.
The information on this site is contained in good faith for general information purposes only. It is not intended to be the advice you should resort to, and we will not give any representations, warranties or warranties, whether express or implied regarding its accuracy or completeness. You should seek expert or expert advice before taking or refraining from taking any medication based on the content on our site.